As a practicing breast radiologist for many years, Dr. Calin Caluser became well aware of the pains and frustrations associated with breast imaging, as confirmed by his colleagues and the professional community. The lack of reproducible and standardized quality breast ultrasound for all patients can limit the access of women to a potentially life saving examination and cause small cancers to be missed or misdiagnosed. Since there was no product able to offer a satisfactory solution, he was determined to find a better way to perform breast mapping.
Together with a small team of engineers and scientists, he started MetriTrack in 2014. They filed multiple patents, and conducted research to develop a system capable of addressing the limitations of breast mapping and provide the solution.
Our team is dedicated to saving lives through the early detection and treatment of breast cancer. We believe our automated breast mapping system will make a significant contribution to the physicians and technologists that share our dedication.
MetriTrack, Inc. is a privately owned medical device technology company focused on advancing the current state of breast cancer care. We provide automated solutions for breast ultrasound. Our innovations are designed to find more breast cancers, faster and at lower cost than possible today.
MetriTrack is privileged to partner with radiology and business experts who comprise our advisory board. Each advisor shares our commitment to helping more women survive breast cancer. Their counsel will continue to contribute to our R&D and Commercialization plans, enabling us to bring our novel technology system to providers and patients worldwide.